News

The collaboration is to develop and market Durect’s Posidur (Saber-bupivacaine) a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials. Reportedly, Hospira is expected to

DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects. Depomed claimed that the

In conjunction with this investment, OptiNose will reincorporate in the US and move its headquarters from Oslo, Norway to Yardley, PA. OptiNose, founded by Per Djupesland in 2000,

Tesetaxel is a late Phase 2 oncology oral taxane product. The data were presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in

By regulation, the FDA has 60 days to conduct a filing review to determine if the application is sufficiently complete to permit a substantive review. Salix has requested

As per the terms of the agreement, Sanofi Pasteur and its affiliates acquire exclusive access to Vivalis’ platform for the discovery of fully human monoclonal antibodies targeting infectious

Atorvastatin, a cholesterol-reducing medicine is a generic equivalent of the Pfizer’s brand Lipitor, a member of the drug class known as statins. It stabilises plaque and prevents strokes

The claims covers the use of granulocyte macrophage colony stimulating factor (GM-CSF) for producing oligodendrocytes from multipotent neural stem cells in culture. This is the second patent to

Rosetta Genomics said that the ongoing study is designed to examine the ability of miRview mets to identify the primary origin of metastases in patients with cancer of